SCHEMBL9527802

SCHEMBL9527802

CC(C)Cc1nc(C(=O)C2CCCCC2)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.43
AGTR2 P50052 5/20 0.43
PPARG P37231 4/20 0.35
PDE6D O43924 1/20 0.35
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
S1PR5 Q9H228 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MLNR O43193 1/20 0.32
NR1I2 O75469 1/20 0.32
USP2 O75604 1/20 0.32
ESR1 P03372 1/20 0.32
NR3C1 P04150 1/20 0.32
TP53 P04637 1/20 0.32
PGR P06401 1/20 0.32
ADRB2 P07550 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRB1 P08588 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529791 0.92 AGTR1 (0.36) AGTR1AGTR2PPARG
SCHEMBL9530272 0.91 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9527886 0.89 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9529490 0.89 AGTR1 (0.42) AGTR1AGTR2PPARGPDE6D
SCHEMBL9531952 0.88 AGTR1 (0.47) AGTR1AGTR2PPARG
SCHEMBL9530088 0.87 AGTR1 (0.34) AGTR1AGTR2PPARG
SCHEMBL9529090 0.87 AGTR1 (0.34) AGTR1AGTR2PPARG
SCHEMBL9698178 0.87 AGTR1 (0.44) AGTR1AGTR2PPARG
SCHEMBL9552556 0.87 TRPV1 (0.37) AGTR1AGTR2PPARG
SCHEMBL6007939 0.86 AGTR1 (0.52) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed